Evidence map›Paper›PMID 41626708›Full record

ArticleInternal medicine journal2026

Caring for Australians and New Zealanders with kidney Impairment guidelines commentary on the Kidney Disease: Improving Global Outcomes clinical practice guideline for management of diabetes and chronic kidney disease.

Hannah Wallace, Mia E Abdy, Kathie Anderson, Effie Johns, Thu Nguyen, Carla Scuderi, Vincent Lee, David J Tunnicliffe, Min Jun, on behalf CARI Guidelines Steering Committee

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hannah WallaceThe George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-2728-4299
Mia E AbdySydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0009-0000-8464-6711
Kathie AndersonThe Children's Hospital at Westmead, Consumer Partner, Melbourne, Victoria, Australia.
Effie JohnsThe Children's Hospital at Westmead, Consumer Partner, Melbourne, Victoria, Australia.
Thu NguyenDepartment of Renal Medicine, Te Toka Tumai Auckland, Auckland, New Zealand.
Carla ScuderiSchool of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia.
Vincent LeeCentre for Kidney Research, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
David J TunnicliffeSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-3270-3475
Min JunThe George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-1460-7535
on behalf CARI Guidelines Steering Committee

Funding

National Health and Medical Research Council APP1197337
6 · The paper itself

Abstract

Diabetes is a leading cause of kidney failure, and individuals with both diabetes and chronic kidney disease (CKD) experience significantly higher rates of complications and mortality. The international guideline developer Kidney Disease: Improving Global Outcomes (KDIGO) has produced clinical practice guidelines that reflect recent advances in pharmacotherapy for this population, extending beyond glycaemic control to include cardio-renal benefits. However, these guidelines were developed without specific consideration of the healthcare systems, access issues and population needs in Australia and New Zealand. In response, the Caring for Australians and New Zealanders with Kidney Impairment (CARI) Guidelines Working Group has provided a regional commentary on the KDIGO 2022 guideline. This commentary highlights key recommendations and contextualises their implementation within the Australian and New Zealand healthcare environments. It addresses issues such as medication access, equity for Indigenous populations and the importance of shared decision-making, aiming to support clinicians in delivering evidence-based, locally relevant care for people living with diabetes and CKD.

Indexed as

Diabetes MellitusDiabetic NephropathiesPractice Guidelines as TopicRenal Insufficiency, ChronicAustralasian PeopleAustraliaHumansNew Zealandchronic kidney diseasediabetes mellitusguidelinesshared decision‐making

Identifiers

PMID41626708
PMCPMC12885105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.